Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies

American Heart Journal

Volumn 160, Issue 4, 2010, Pages

  Kong, Melissa H ^a   Peterson, Eric D ^a   Fonarow, Gregg C ^b   Sanders, Gillian D ^a   Yancy, Clyde W ^c   Russo, Andrea M ^d   Curtis, Anne B ^e   Sears Jr , Samuel F ^f   Thomas, Kevin L ^a   Campbell, Susan ^g   Carlson, Mark D ^h   Chiames, Chris ⁱ   Cook, Nakela L ^j   Hayes, David L ^k   Larue, Michelle ^l   Hernandez, Adrian F ^a   Lyons, Edward L ^m   Al Khatib, Sana M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d Department of Anesthesiology   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f EAST CAROLINA UNIVERSITY   (United States)

^g WomenHeart: National Coalition for Women with Heart Disease   (United States)

^h St Jude Medical Inc USA   (United States)

ⁱ Sudden Cardiac Arrest Association   (United States)

^j NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^k MAYO CLINIC   (United States)

^l National Alliance for Hispanic Health   (United States)

^m GE HEALTHCARE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE TO HEALTH; CARDIOLOGY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CULTURAL ANTHROPOLOGY; ETHNIC DIFFERENCE; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; FUNCTIONAL STATUS; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEART ARREST; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; MEDICAID; MEDICARE; OUTPATIENT CARE; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT SATISFACTION; PERIPHERAL VASCULAR DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SUDDEN DEATH; SURVIVAL; TOTAL QUALITY MANAGEMENT; UNITED STATES; DEATH, SUDDEN, CARDIAC; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PROCEDURES; UTILIZATION;

DEATH, SUDDEN, CARDIAC; HEALTHCARE DISPARITIES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); SOCIETIES, MEDICAL; UNITED STATES;

EID: 77958047021     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.07.011     Document Type: Article

References (54)

1. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
2. Hjalmarson A., Goldstein S., and Fagerberg B. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group JAMA 283 2000 1295 1302
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators N Engl J Med 325 1991 293 302
4. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group N Engl J Med 316 1987 1429 1435
5. Pitt B., Remme W., and Zannad F. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
6. Pitt B., Zannad F., and Remme W.J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
7. Moss A.J., Zareba W., and Hall W.J. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
8. Bardy G.H., Lee K.L., and Mark D.B. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
9. Epstein A.E., DiMarco J.P., and Ellenbogen K.A. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J Am Coll Cardiol 51 2008 e1 e62
10. Fonarow G.C., Abraham W.T., and Albert N.M. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design Am Heart J 148 2004 43 51
11. Fonarow G.C. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF Rev Cardiovasc Med 5 Suppl 1 2004 S45 S54
12. Lee D.S., Tu J.V., and Juurlink D.N. Risk-treatment mismatch in the pharmacotherapy of heart failure JAMA 294 2005 1240 1247
13. Al-Khatib S.M., Sanders G.D., and Carlson M. Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention Am Heart J 156 2008 613 622
14. National Medical Association: Sudden Cardiac Arrest Leadership Conference white paper. Sudden cardiac arrest: advancing awareness and bridging gaps to improve survival. Washington, D.C., 2008.
15. Zheng Z.J., Croft J.B., and Giles W.H. Sudden cardiac death in the United States, 1989 to 1998 Circulation 104 2001 2158 2163
16. Gillum R.F. Sudden coronary death in the United States: 1980-1985 Circulation 79 1989 756 765
17. Cobb L.A., Fahrenbruch C.E., and Olsufka M. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000 JAMA 288 2002 3008 3013
18. Escobedo L.G., and Zack M.M. Comparison of sudden and nonsudden coronary deaths in the United States Circulation 93 1996 2033 2036
19. Nichol G., Thomas E., and Callaway C.W. Regional variation in out-of-hospital cardiac arrest incidence and outcome JAMA 300 2008 1423 1431
20. Chugh S.S., Jui J., and Gunson K. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community J Am Coll Cardiol 44 2004 1268 1275
21. Goldberg R.J., Gorak E.J., and Yarzebski J. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease Circulation 87 1993 1947 1953
22. Ghanbari H., Dalloul G., and Hasan R. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials Arch Intern Med 169 2009 1500 1506
23. Dries D.L., Exner D.V., and Gersh B.J. Racial differences in the outcome of left ventricular dysfunction N Engl J Med 340 1999 609 616
24. American Heart Association Heart disease and stroke statistics-2010 update 2010 American Heart Association Dallas (TX)
25. Chan P.S., Nichol G., and Krumholz H.M. Racial differences in survival after in-hospital cardiac arrest JAMA 302 2009 1195 1201
26. Galea S., Blaney S., and Nandi A. Explaining racial disparities in incidence of and survival from out-of-hospital cardiac arrest Am J Epidemiol 166 2007 534 543
27. Albert N.M., Yancy C.W., and Liang L. Use of aldosterone antagonists in heart failure JAMA 302 2009 1658 1665
28. Fonarow G.C., Yancy C.W., and Heywood J.T. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry Arch Intern Med 165 2005 1469 1477
29. Lewis W.R., Ellrodt A.G., and Peterson E. Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program Circ Cardiovasc Qual Outcomes 2 2009 633 641
30. Hernandez A.F., Fonarow G.C., and Liang L. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure JAMA 298 2007 1525 1532
31. Gauri A.J., Davis A., and Hong T. Disparities in the use of primary prevention and defibrillator therapy among blacks and women Am J Med 119 2006 e17 e21
32. Groeneveld P.W., Heidenreich P.A., and Garber A.M. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography J Am Coll Cardiol 45 2005 72 78
33. Chan P.S., Birkmeyer J.D., and Krumholz H.M. Racial and gender trends in the use of implantable cardioverter-defibrillators among Medicare beneficiaries between 1997 and 2003 Congest Heart Fail 15 2009 51 57
34. Groeneveld P.W., Heidenreich P.A., and Garber A.M. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest Circulation 108 2003 286 291
35. Thomas K.L., Al-Khatib S.M., and Kelsey R.C. Jr. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of < or =35% Am J Cardiol 100 2007 924 929
36. Curtis L.H., Al-Khatib S.M., and Shea A.M. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death JAMA 298 2007 1517 1524
37. Mehra M.R., Yancy C.W., and Albert N.M. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: findings from IMPROVE HF Heart Rhythm 6 2009 1727 1734
38. Fonarow G.C., Yancy C.W., and Albert N.M. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry Am Heart J 154 2007 12 38
39. Silagy C.A., Weller D.P., and Lapsley H. The effectiveness of local adaptation of nationally produced clinical practice guidelines Fam Pract 19 2002 223 230
40. Cranney M., Warren E., and Barton S. Why do GPs not implement evidence-based guidelines? A descriptive study Fam Pract 18 2001 359 363
41. Fonarow G.C., Yancy C.W., and Albert N.M. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF Circ Heart Fail 1 2008 98 106
42. Fonarow G.C., Abraham W.T., and Albert N.M. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF) Am J Cardiol 104 2009 107 115
43. Califf R.M., Harrington R.A., and Madre L.K. Curbing the cardiovascular disease epidemic: aligning industry, government, payers, and academics Health Aff (Millwood) 26 2007 62 74
44. Sears S.F., Matchett M., and Conti J.B. Effective management of ICD patient psychosocial issues and patient critical events J Cardiovasc Electrophysiol 2009
45. Hunt S.A., Abraham W.T., and Chin M.H. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society Circulation 112 2005 e154 e235
46. Ramza B.M., Kao A.C., and Daniel W.C. American Heart Association 2007 scientific sessions abstract #3274 Circulation 116 2007 II 737
47. Haynes R.B., Devereaux P.J., and Guyatt G.H. Clinical expertise in the era of evidence-based medicine and patient choice ACP J Club 136 2002 A11 14
48. Fonarow G.C. The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes Rev Cardiovasc Med 3 Suppl 3 2002 S2 S10
49. Fonarow G.C., Yancy C.W., and Albert N.M. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of IMPROVE HF Journal of Cardiac Failure 15 2009 813
50. Fonarow G.C., Albert N.M., and Cannom D. Sudden cardiac arrest prevention pathways and tools Crit Pathw Cardiol 8 2009 79 87
51. Curtis J.P., Luebbert J.J., and Wang Y. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator JAMA 301 2009 1661 1670
52. Fonarow G.C., Abraham W.T., and Albert N.M. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J 153 2007 e1 e11
53. Tu J.V., Donovan L.R., and Lee D.S. Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial JAMA 302 2009 2330 2337
54. Zipes D.P., Camm A.J., and Borggrefe M. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e385 e484